Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	28.85	31.17	73.98	50.71	71.72	9.77
Short-Term Investments	42.54	73.94	22.52	106.51	151.16	54.38
Cash & Short-Term Investments	71.38	105.11	96.5	157.22	222.88	64.16
Cash Growth	-55.53%	8.92%	-38.62%	-29.46%	247.39%	-37.87%
Accounts Receivable	33.38	12.1	-	-	-	8.28
Other Receivables	0.93	1.32	2.25	31.54	38.44	3.69
Receivables	34.3	13.43	2.25	31.54	38.44	11.98
Inventory	13.31	10.38	-	-	-	3.57
Prepaid Expenses	6.11	4.37	1.52	3.18	1.02	2.12
Other Current Assets	0.67	0.91	0.57	0.55	1.12	0.56
Total Current Assets	125.78	134.2	100.84	192.49	263.45	82.38
Property, Plant & Equipment	14.51	13.08	13.24	11.49	8.16	10.58
Goodwill	16.84	16.84	16.84	16.84	16.84	18.49
Other Intangible Assets	-	-	-	-	-	0.81
Long-Term Deferred Tax Assets	-	-	-	24.13	18.26	29.43
Other Long-Term Assets	0.39	0.58	1.87	2.33	4.93	9.74
Total Assets	157.52	164.7	132.79	247.27	311.64	151.44
Accounts Payable	9.79	11.43	7.89	7.68	2.93	6.1
Accrued Expenses	22.56	20.18	8.51	12.03	8.68	19.56
Current Portion of Long-Term Debt	-	-	37.67	-	-	5.55
Current Portion of Leases	0.87	0.93	0.96	0.9	0.47	0.65
Other Current Liabilities	11.39	4.31	0.77	0.39	3.03	4.13
Total Current Liabilities	44.61	36.86	55.79	21	15.11	35.98
Long-Term Debt	35.49	32.76	91.61	142.4	128.21	121.69
Long-Term Leases	1.31	1.69	0.78	1.71	1.84	2.32
Other Long-Term Liabilities	5.82	5.65	5.74	3.92	4.21	20.65
Total Liabilities	87.23	76.96	153.93	169.02	149.37	180.64
Common Stock	0.96	0.9	0.63	0.59	0.58	0.43
Additional Paid-In Capital	880.2	855.45	589.78	549.35	566.92	434.39
Retained Earnings	-786.66	-745.5	-585.22	-447.76	-384.19	-391.22
Treasury Stock	-	-	-	-	-	-50
Comprehensive Income & Other	-24.22	-23.17	-26.34	-23.94	-21.05	-22.81
Total Common Equity	70.29	87.69	-21.15	78.24	162.26	-29.2
Shareholders' Equity	70.29	87.74	-21.15	78.24	162.27	-29.2
Total Liabilities & Equity	157.52	164.7	132.79	247.27	311.64	151.44
Total Debt	37.67	35.38	131.02	145	130.52	130.2
Net Cash (Debt)	33.72	69.73	-34.52	12.22	92.36	-66.05
Net Cash Growth	-75.64%	-	-	-86.77%	-	-
Net Cash Per Share	0.37	0.87	-0.57	0.21	1.68	-1.77
Filing Date Shares Outstanding	96.27	90.58	64.48	59.03	58.47	46.4
Total Common Shares Outstanding	96.2	89.83	62.88	58.62	58.4	37.52
Working Capital	81.17	97.35	45.05	171.49	248.35	46.4
Book Value Per Share	0.73	0.98	-0.34	1.33	2.78	-0.78
Tangible Book Value	53.45	70.85	-37.99	61.4	145.43	-48.5
Tangible Book Value Per Share	0.56	0.79	-0.60	1.05	2.49	-1.29
Machinery	-	0.63	0.63	0.3	0.3	0.3

Source: S&P Capital IQ. Standard template. Financial Sources.